The Alzheimer’s Association has launched the Brain Health & Quality Care Initiative to help health care organizations improve early detection, diagnosis and treatment of Alzheimer’s disease and other forms of dementia. The initiative will initially focus on primary care, providing clinicians with evidence-based guidance, training and resources, with Eisai and Eli Lilly and Company serving as its first founding partners.
